IPO - BCLS SB Investco, LP

Form Type: SCHEDULE 13D/A

Filing Date: 2025-02-21

Corporate Action: Ipo

Type: Update

Accession Number: 000095017025025036

Filing Summary: This document is an amendment (Amendment No. 10) to the Schedule 13D, initially filed by BCLS SB Investco, LP on February 1, 2018, concerning its ownership of Common Stock of Solid Biosciences Inc. On February 18, 2025, the Issuer executed an underwriting agreement for a public offering of 35,739,810 shares of its Common Stock and pre-funded warrants for an additional 13,888,340 shares. The public offering concluded on February 19, 2025, priced at $4.03 per share. BCLS II Investco participated in this offering, acquiring 1,000,000 shares and a pre-funded warrant for 6,444,170 shares at a total cost of $29,993,561. Following the offering, the Reporting Persons collectively beneficially own 9.99% of Solid Biosciences Inc.'s outstanding shares, totaling 7,911,669 shares. The document outlines the restrictions on the exercise of the pre-funded warrants and the implications of ownership exceeding the threshold limits as defined under relevant regulations.

Document Link: View Document